Intracellular coexpression of CXC- and CC– chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation

[1]  L. Sommer,et al.  Testing the cancer stem cell hypothesis in melanoma: the clinics will tell. , 2013, Cancer letters.

[2]  Jiyeon Han,et al.  CXCR7 mediates SDF1‐induced melanocyte migration , 2013, Pigment cell & melanoma research.

[3]  T. Hagemann,et al.  The tumor microenvironment at a glance , 2012, Journal of Cell Science.

[4]  M. Groettrup,et al.  Ubiquitylation of the chemokine receptor CCR7 enables efficient receptor recycling and cell migration , 2012, Journal of Cell Science.

[5]  J. Annereau,et al.  Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells , 2012, PloS one.

[6]  A. Pellín,et al.  CCL27–CCR10 and CXCL12–CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma , 2012, Clinical & Experimental Metastasis.

[7]  J. Cigudosa,et al.  Characterization of a new human melanoma cell line with CD133 expression , 2012, Human Cell.

[8]  F. Balkwill.  The chemokine system and cancer , 2012, The Journal of pathology.

[9]  S. Shimizu,et al.  CXCR7 Protein Expression in Human Adult Brain and Differentiated Neurons , 2011, PloS one.

[10]  Jian Zhang,et al.  CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression , 2010, Cancer and Metastasis Reviews.

[11]  A. Mantovani,et al.  Chemokine receptors intracellular trafficking. , 2010, Pharmacology & therapeutics.

[12]  L. Mariani,et al.  Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells. , 2010, The Journal of investigative dermatology.

[13]  H. Redmond,et al.  Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4 , 2010, BMC Cancer.

[14]  A. Giaccia,et al.  Hypoxia, inflammation, and the tumor microenvironment in metastatic disease , 2010, Cancer and Metastasis Reviews.

[15]  J. Maris,et al.  CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation , 2009, Molecular Cancer.

[16]  A. Richmond,et al.  The good and the bad of chemokines/chemokine receptors in melanoma , 2009, Pigment cell & melanoma research.

[17]  R. Tollenaar,et al.  Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer Patients , 2008, Cancer Microenvironment.

[18]  E. Thiel,et al.  Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis. , 2008, Human pathology.

[19]  T. Sanke,et al.  Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis , 2008, BMC Cancer.

[20]  S. Marullo,et al.  An escort for GPCRs: implications for regulation of receptor density at the cell surface. , 2008, Trends in pharmacological sciences.

[21]  J. Lévesque,et al.  Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. , 2008, Stem cells and development.

[22]  J. Van Damme,et al.  The role of CXC chemokines and their receptors in cancer. , 2008, Cancer letters.

[23]  D. Jo,et al.  Cytoplasmic trapping of CXCR4 in hepatocellular carcinoma cell lines. , 2008, Cancer research and treatment : official journal of Korean Cancer Association.

[24]  J. Niederkorn,et al.  Differential expression of chemokine receptors on uveal melanoma cells and their metastases. , 2008, Investigative ophthalmology & visual science.

[25]  Mohamed H. Sayegh,et al.  Identification of cells initiating human melanomas , 2008, Nature.

[26]  Guangyu Wu,et al.  Regulation of anterograde transport of adrenergic and angiotensin II receptors by Rab2 and Rab6 GTPases. , 2007, Cellular signalling.

[27]  O. Fodstad,et al.  Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts. , 2007, Cancer genomics & proteomics.

[28]  Tracy M Handel,et al.  Chemokine: receptor structure, interactions, and antagonism. , 2007, Annual review of immunology.

[29]  B. Sipos,et al.  The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver. , 2006, Cancer research.

[30]  Robert J. Lefkowitz,et al.  Compartmentation of Cyclic Nucleotide Signaling in the Heart: The Role of Cyclic Nucleotide Phosphodiesterases , 2012 .

[31]  Kevin Wei,et al.  A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development , 2006, The Journal of experimental medicine.

[32]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[33]  C. Rubini,et al.  Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape. , 2006, European journal of cancer.

[34]  S. Hwang,et al.  Chemokines, chemokine receptors, and cancer metastasis , 2006, Journal of leukocyte biology.

[35]  A. Llombart‐Bosch,et al.  CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors , 2006, Journal of Clinical Pathology.

[36]  N. Longo,et al.  Clinical significance of CXCR3 and CXCR4 expression in primary melanoma , 2005, International journal of cancer.

[37]  S. Segerer,et al.  CCR10 is expressed in cutaneous T‐cell lymphoma , 2005, International journal of cancer.

[38]  T. Murakami,et al.  Chemokine receptors and melanoma metastasis. , 2004, Journal of dermatological science.

[39]  F. Balkwill,et al.  The chemokine network in cancer--much more than directing cell movement. , 2004, The International journal of developmental biology.

[40]  T. Manabe,et al.  Pivotal Role of CXCR3 in Melanoma Cell Metastasis to Lymph Nodes , 2004, Cancer Research.

[41]  Christopher M. Tan,et al.  Membrane trafficking of G protein-coupled receptors. , 2004, Annual review of pharmacology and toxicology.

[42]  K. Matsushima,et al.  Pivotal role of CCL25 (TECK)-CCR9 in the formation of gut cryptopatches and consequent appearance of intestinal intraepithelial T lymphocytes. , 2002, International immunology.

[43]  N. Longo,et al.  Expression of Functional Chemokine Receptors CXCR3 and CXCR4 on Human Melanoma Cells* , 2001, The Journal of Biological Chemistry.

[44]  J. O'connor,et al.  The Relevance of Flow Cytometry for Biochemical Analysis , 2001, IUBMB life.

[45]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[46]  H. Flad,et al.  Identification of Distinct Surface-Expressed and Intracellular CXC-Chemokine Receptor 2 Glycoforms in Neutrophils: N-Glycosylation Is Essential for Maintenance of Receptor Surface Expression1 , 2000, The Journal of Immunology.

[47]  S. Tóth,et al.  Autocrine and paracrine regulation by cytokines and growth factors in melanoma. , 2000, Cytokine.

[48]  J. Cyster,et al.  Chemokines and cell migration in secondary lymphoid organs. , 1999, Science.

[49]  F. Torti,et al.  Genetic co-inactivation of macrophage- and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines , 1998, Gene Therapy.

[50]  X F Huang,et al.  Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Nowell,et al.  Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. , 1985, Journal of the National Cancer Institute.

[52]  A. Ben-Baruch.  Organ selectivity in metastasis: regulation by chemokines and their receptors , 2007, Clinical & Experimental Metastasis.